Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Charles River Laboratories has appointed former FDA Principal Deputy Commissioner Namandjé N. Bumpus, Ph.D., to chair its newly established Scientific Advisory Board, guiding the company’s strategy to advance New Approach Methodologies (NAMs) that ...
read more
Patheon has announced the appointment of Gilles Cottier as president of the company’s pharmaceutical development services (PDS) division effective immediately. He will serve as a member of Patheon’s executive committee and will report to Patheon CEO ...
read more
Gary Tanner, a former executive at Valeant Pharmaceuticals, and Andrew Davenport, the former CEO of Philidor Rx Services, for engaging in a multimillion-dollar kickback scheme.
read more
Wednesday, September 08, 2021
For over 20 years, Formulated Solutions has been driven to create more ideal consumer and patient experiences in Pharmaceutical and Self-Directed Consumer Healthcare. In support of that adherence-focused mission, Formulated Solutions is proud to ...
read more
Monday, December 19, 2022
Formulated Solutions announced an agreement to acquire a newly updated 455,000 ft2 FDA approved pharmaceutical liquids, semi solids, aerosol, BoV, and metered dose nasal spray production facility located in Cleveland, TN.
read more
Formycon AG and OneSource Specialty Pharma have entered a strategic manufacturing partnership to support Formycon’s biosimilar programs for global markets.
read more
Fortress Biotech announced Oncogenuity has an agreement with Columbia University to develop novel oligonucleotides for the treatment of genetically driven cancers.
read more
Monday, December 23, 2019
Fortress Biotech announced Baergic Bio entered into an agreement with AstraZeneca for AZD7325, a novel a2/3–subtype-selective GABA A PAM, as well as an agreement with Cincinnati Children’s Hospital Medical Center to advance clinical development in ...
read more
Caelum Biosciences has entered a biopharmaceutical manufacturing agreement with Patheon for process development and current cGMP production of Caelum’s lead therapy CAEL-101.
read more
Thursday, January 10, 2019
ArisGlobal announced that China-based Fosun Pharma has selected LifeSphere Safety MultiVigilance (LSMV) as its global pharmacovigilance system.
read more
Medidata announced an enterprise agreement with Chinese healthcare group, Shanghai Fosun Pharmaceutical.
read more
Wednesday, January 17, 2018
Foundation Medicine announced the company has entered into a broad partnership with Pfizer.
read more
The Abramson Cancer Center at the University of Pennsylvania, The Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center, the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, and The Tisch Cancer Institute at the ...
read more
Framework Solutions announced the appointment of Russ Belden as Head of Commercial Solutions, effective April 26th, 2023.
read more
Tuesday, December 06, 2022
Fraunhofer IZI, one of Europe’s leading manufacturers of cell and gene therapies for clinical trials, intends to digitalize its manufacturing operations with MODA-ES®, the Manufacturing Execution System from Lonza. Fraunhofer IZI will use Lonza’s ...
read more